Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618980.RA0iRUV3t3g_Ee_t83kEs9WCO2FC-nR0Jg6klk_fqax5I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618980.RA0iRUV3t3g_Ee_t83kEs9WCO2FC-nR0Jg6klk_fqax5I130_assertion type Assertion NP618980.RA0iRUV3t3g_Ee_t83kEs9WCO2FC-nR0Jg6klk_fqax5I130_head.
- NP618980.RA0iRUV3t3g_Ee_t83kEs9WCO2FC-nR0Jg6klk_fqax5I130_assertion description "[Their levels fell further with increasing tumour's stage and were higher in tumours from patients who remained disease free compared with those who developed local recurrence or distant metastasis or died from breast cancer.TRF2 showed a trend similar to that of TANK2 and POT1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618980.RA0iRUV3t3g_Ee_t83kEs9WCO2FC-nR0Jg6klk_fqax5I130_provenance.
- NP618980.RA0iRUV3t3g_Ee_t83kEs9WCO2FC-nR0Jg6klk_fqax5I130_assertion evidence source_evidence_literature NP618980.RA0iRUV3t3g_Ee_t83kEs9WCO2FC-nR0Jg6klk_fqax5I130_provenance.
- NP618980.RA0iRUV3t3g_Ee_t83kEs9WCO2FC-nR0Jg6klk_fqax5I130_assertion SIO_000772 17616810 NP618980.RA0iRUV3t3g_Ee_t83kEs9WCO2FC-nR0Jg6klk_fqax5I130_provenance.
- NP618980.RA0iRUV3t3g_Ee_t83kEs9WCO2FC-nR0Jg6klk_fqax5I130_assertion wasDerivedFrom befree-2016 NP618980.RA0iRUV3t3g_Ee_t83kEs9WCO2FC-nR0Jg6klk_fqax5I130_provenance.
- NP618980.RA0iRUV3t3g_Ee_t83kEs9WCO2FC-nR0Jg6klk_fqax5I130_assertion wasGeneratedBy ECO_0000203 NP618980.RA0iRUV3t3g_Ee_t83kEs9WCO2FC-nR0Jg6klk_fqax5I130_provenance.